The revenue of REGAL REXNORD CORP over the past 10 years
Chart REGAL REXNORD CORP: revenue, fiscal 2016–2025 Open the chart →REGAL REXNORD CORP reported revenue of $5.93B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $3.22B — up 84% over 9 years. Year over year, revenue rose 5 times and fell 4 times. In these years the highest was $6.25B in fiscal 2023; the lowest $2.91B in fiscal 2020. The largest one-year move was in fiscal 2022: up 37%, from $3.81B to $5.22B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $5.93B |
| 2024ended Dec 31, 2024 | $6.03B |
| 2023ended Dec 31, 2023 | $6.25B |
| 2022ended Dec 31, 2022 | $5.22B |
| 2021ended Jan 1, 2022 | $3.81B |
| 2020ended Jan 2, 2021 | $2.91B |
| 2019ended Dec 28, 2019 | $3.24B |
| 2018ended Dec 29, 2018 | $3.65B |
| 2017ended Dec 30, 2017 | $3.36B |
| 2016ended Dec 31, 2016 | $3.22B |
Fiscal years as REGAL REXNORD CORP reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on REGAL REXNORD CORP
- The profitability of REGAL REXNORD CORP
- The cash flow of REGAL REXNORD CORP
- The debt of REGAL REXNORD CORP
- The dividends of REGAL REXNORD CORP
- All of REGAL REXNORD CORP's financials, charted
Companies of a similar size
- MUSAMURPHY USA INC.
- PTGXProtagonist Therapeutics, Inc
- BXPBXP, INC.
- NTSKNetskope, Inc.
- BIOBIO-RAD LABORATORIES, INC.
Not investment advice. This page shows what REGAL REXNORD CORP filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.